The ePrescibing market is expected to be valued at US$ 4.8 billion in 2024. The market is projected to expand at a CAGR of 27.1% from 2024 to 2034. By 2034, the market value is forecasted to reach a valuation of US$ 52.2 billion.
The healthcare industry has seen a surge in demand for electronic prescribing systems that offer accurate medication management and reduce errors to improve patient outcomes. This has resulted in regulatory pressure from governments and healthcare bodies to adopt ePrescribing systems and embrace digital tools for medication management.
Request A Sample Copy of This Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-19013The demand for ePrescribing solutions is further driven by the rising prevalence of chronic diseases and the growing elderly population. Patients with complex medication regimes often require multiple prescriptions, making it necessary to have accurate and efficient medication management systems in place.
Cloud-based ePrescribing solutions have gained popularity due to their scalability, flexibility, and cost-effectiveness. Healthcare providers can access patient data and medication information from anywhere, at any time, with the help of cloud-based systems, making it easier to deliver high-quality care to patients.
The increasing adoption of healthcare information technology (IT) solutions by healthcare providers is driving the electronic health record (EHR) systems. ePrescribing is often integrated with EHRs to provide a more streamlined and efficient medication management process. The trend of telemedicine and remote patient care, especially amidst the COVID-19 pandemic, is driving growth in the market.
“The market is expected to continue to grow in the coming years, driven by the increasing demand for electronic prescribing systems that can help reduce medication errors and improve patient outcomes,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Key Takeaways from the ePrescibing Market:
The global ePriscribing market is estimated to register a CAGR of 27.1% and reach a valuation of US$ 52.2 billion by 2034.
The solutions segment is anticipated to dominate the market by registering a 26.9% CAGR from 2024 to 2034.
With a CAGR of 26.7% through 2034, the web/cloud-based delivery mode is highly preferred by patients.
Act Now to Explore In-Depth Market Analysis: Purchase Now to Access Market Insights:
https://www.futuremarketinsights.com/checkout/19013Competitive Landscape:
The ePrescribing market is a dynamic and evolving industry, with the emergence of new players offering a wide range of solutions such as software platforms, mobile applications, and cloud-based services. As the demand for ePrescribing services continues to grow, smaller companies and start-ups are entering the market with innovative solutions to meet the evolving needs of healthcare providers and patients.
The competition in the ePrescribing market is fierce, and companies are constantly seeking ways to differentiate themselves by offering unique features and capabilities. As a result, the market is constantly evolving, and it is essential for companies to stay ahead of the competition by offering innovative solutions that meet the needs of their customers.
Key Market Players:
Surescripts
Allscripts Healthcare Solutions, Inc.
Cerner Corporation
GE Healthcare
RelayHealth Corporation
Athenahealth, Inc.
DrFirst, Practice Fusion Inc.
Medical Information Technology, Inc.
Henry Schein, Inc.
Locked
